Strongbridge Bio Ord (SBBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 10,042 | 8,382 | 8,226 | 8,071 | 7,760 |
| Cost of Goods | 467 | 411 | 442 | 408 | 393 |
| Gross Profit | 9,575 | 7,971 | 7,784 | 7,663 | 7,367 |
| Operating Expenses | 23,107 | 18,452 | 18,623 | 17,655 | 17,438 |
| Operating Income | -13,065 | -10,070 | -10,397 | -9,584 | -9,678 |
| Interest Expense | 810 | 782 | 560 | 523 | 253 |
| Other Income | 635 | -962 | -1,004 | 6,948 | -7,341 |
| Pre-tax Income | -13,240 | -11,814 | -11,961 | -3,159 | -17,272 |
| Income Tax | 1 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -13,241 | -11,814 | -11,946 | -3,159 | -17,272 |
| Net Income | $-13,241 | $-11,814 | $-11,946 | $-3,159 | $-17,272 |
| EPS Basic Total Ops | -0.20 | -0.18 | -0.17 | -0.06 | -0.32 |
| EPS Basic Continuous Ops | -0.20 | -0.18 | -0.17 | -0.06 | -0.32 |
| EPS Diluted Total Ops | -0.21 | -0.18 | -0.04 | -0.18 | -0.32 |
| EPS Diluted Continuous Ops | -0.19 | -0.18 | -0.17 | -0.06 | -0.32 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.18 | -0.18 | -0.18 | -0.32 |
| EBITDA(a) | $-11,788 | $-8,793 | $-9,120 | $-8,308 | $-8,401 |